D
Debra Burdick
Researcher at Novartis
Publications - 5
Citations - 644
Debra Burdick is an academic researcher from Novartis. The author has contributed to research in topics: Cell & Allosteric regulation. The author has an hindex of 4, co-authored 5 publications receiving 463 citations.
Papers
More filters
Journal ArticleDOI
Selective VPS34 inhibitor blocks autophagy and uncovers a role for NCOA4 in ferritin degradation and iron homeostasis in vivo
William E. Dowdle,Beat Nyfeler,Jane Nagel,Robert Elling,Shanming Liu,Ellen Triantafellow,Suchithra Menon,Zuncai Wang,Ayako Honda,Gwynn Pardee,John Cantwell,Catherine Luu,Ivan Cornella-Taracido,Edmund Harrington,Peter Fekkes,Hong Lei,Qing Fang,Mary Ellen Digan,Debra Burdick,Andrew F. Powers,Stephen B. Helliwell,Simon D’Aquin,Julie Bastien,Henry Wang,Dmitri Wiederschain,Jenny Kuerth,Philip Bergman,David Schwalb,Jason R. Thomas,Savuth Ugwonali,Fred Harbinski,John A. Tallarico,Christine D. Wilson,Vic E. Myer,Jeffery A. Porter,Dirksen E. Bussiere,Peter Finan,Mark Labow,Xiaohong Mao,Lawrence G. Hamann,Brendan D. Manning,Reginald Valdez,Thomas B. Nicholson,Markus Schirle,Mark Knapp,Erin P. Keaney,Leon Murphy +46 more
TL;DR: a4−/− mice exhibit a profound accumulation of iron in splenic macrophages, which are critical for the reutilization of iron from engulfed red blood cells, and a previously unappreciated role for autophagy and NCOA4 in the control of iron homeostasis in vivo is revealed.
Journal ArticleDOI
Small-molecule WNK inhibition regulates cardiovascular and renal function
Ken Yamada,Hyi-Man Park,Dean F. Rigel,Keith DiPetrillo,Whalen Ej,Anisowicz A,Beil M,Berstler J,Brocklehurst Ce,Debra Burdick,Caplan Sl,Michael Paul Capparelli,Chen G,Chen W,Dale B,Lin Deng,Fu F,Hamamatsu N,Harasaki K,Herr T,Hoffmann P,Hu Qy,Huang Wj,Neeraja Idamakanti,Hidetomo Imase,Yuki Iwaki,Monish Jain,Jeyaseelan J,Kato M,Virendar K. Kaushik,Darcy Kohls,Kunjathoor,Daniel LaSala,Lee J,Liu J,Luo Y,Mo R,Mowbray S,Muneto Mogi,Ossola F,Pramod Pandey,Sejal Patel,Raghavan S,Salem B,Shanado Yh,Trakshel Gm,Gordon M. Turner,Wakai H,Wang C,Weldon S,Wielicki Jb,Xie X,Xu L,Yukiko I. Yagi,Kayo Yasoshima,Yin J,David Yowe,Jeff Zhang,Zheng G,Lauren G. Monovich +59 more
TL;DR: In rodent models of hypertension, WNK463 affects blood pressure and body fluid and electro-lyte homeostasis, consistent with WNK-kinase-associated physiology and pathophysiology.
Journal ArticleDOI
Discovery and Characterization of Allosteric WNK Kinase Inhibitors.
Ken Yamada,Ji-Hu Zhang,Xiaoling Xie,Reinhardt Juergen,Amy Qiongshu Xie,Daniel LaSala,Darcy Kohls,David Yowe,Debra Burdick,Hajime Yoshisue,Hiromichi Wakai,Isabel Schmidt,Jason Gunawan,Kayo Yasoshima,Q. Kimberley Yue,Mitsunori Kato,Muneto Mogi,Neeraja Idamakanti,Natasha Kreder,Peter Drueckes,Pramod Pandey,Toshio Kawanami,Waan-Jeng Huang,Yukiko I. Yagi,Zhan Deng,Hyi-Man Park +25 more
TL;DR: This work applied the latter approach to the With-No-Lysine (K) (WNK) kinases to discover lead molecules for a next-generation antihypertensive that requires a stringent safety profile, yielding several ATP noncompetitive WNK1-4 kinase inhibitors that inhibited rubidium uptake by sodium chloride cotransporter 1 in HT29 cells, consistent with the reported physiology of WNK kinases in renal electrolyte handling.
Journal ArticleDOI
Identification of a PCSK9-LDLR disruptor peptide with in vivo function.
Margaret E. Brousseau,Kevin B. Clairmont,Glen Spraggon,Flyer Alec,Andrei Golosov,Philipp Grosche,Jakal Amin,Jerome Andre,Debra Burdick,Shari L. Caplan,Guanjing Chen,Raj Chopra,Lisa Ames,Diana Dubiel,Li Fan,Raphael Gattlen,Dawn Kelly-Sullivan,Alexander W. Koch,Ian Lewis,Jingzhou Li,Eugene Liu,Danuta Lubicka,Andreas Marzinzik,Katsumasa Nakajima,David Nettleton,Johannes Ottl,Meihui Pan,Patel Tajesh Jayprakash,Lauren Perry,Stephanie Pickett,Jennifer Poirier,Patrick C. Reid,Xavier Pelle,Mohindra Seepersaud,Vanitha Subramanian,Victoria Vera,Mei Xu,Lihua Yang,Qing Yang,jinghua yu,Guoming Zhu,Lauren G. Monovich +41 more
TL;DR: In this article, an affinity-based screen was employed to identify high-affinity PCSK9 ligands that utilize a unique, induced-fit pocket and partially disrupt the PCSK 9-LDLR interaction.
Journal ArticleDOI
Living with Irresolute Cell Lines in an Automated World
TL;DR: The use of the SelecT automated cell-culture platform is described herein in the authors' discovery and preclinical profiling programs at Novartis, and achieving the balance between cells and the automated environment, and accommodating variable cell dynamics are discussed.